Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

City of Hope

Status: Completed

Conditions: Stage IIB Colon Cancer; Stage IIIA Colon Cancer; Stage IIB Non-small Cell Lung Cancer; Stage IB Non-small Cell Lung Cancer; Stage IIA Non-small Cell Lung Cancer; Stage IIC Colon Cancer; Stage IIA Colon Cancer; Stage IIIB Colon Cancer; Stage IIA Rectal Cancer; Stage IIIC Colon Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIC Rectal Cancer; Stage I Colon Cancer; Stage I Rectal Cancer; Stage IIB Rectal Cancer; Stage IIIB Rectal Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IIIC Rectal Cancer; Stage IA Non-small Cell Lung Cancer; Stage IIIA Rectal Cancer

Treatments: Procedure: quality-of-life assessment; Other: educational intervention; Other: questionnaire administration

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT01741636

NCI-2012-02783 (Registry Identifier)

12342

Details and patient eligibility

About

Survivorship Care Planning may improve overall well-being and quality of life of colorectal and lung cancer survivors

Full description

PRIMARY OBJECTIVES:

I. To test the feasibility and acceptability of an Advanced Practice Nurse (APN) driven Survivorship Care Planning (SCP) intervention for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) survivors.

SECONDARY OBJECTIVES:

I. Development of the infrastructure and strategy for a larger comparative intervention study.

OUTLINE:

Patients undergo Survivorship Care Planning comprising disease surveillance, management of potential long-term and late effects, psycho-social-spiritual issues, and healthy living recommendations.

Enrollment: 30 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Pathologically confirmed diagnosis of stage I, II, or III CRC or NSCLC
• Able to read and understand English
• Able to read and/or understand the study protocol requirements, and provide written informed consent
• Diagnosis of CRC or NSCLC
• Within three months of completing primary treatment (surgery, chemotherapy, radiation, or chemoradiation)
• Without recurrent or new primary cancers

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Supportive care (survivorship plan)

Experimental group

Description:

Patients undergo Survivorship Care Planning comprising disease surveillance, management of potential long-term and late effects, psycho-social-spiritual issues, and healthy living recommendations.

Treatment:

Other: questionnaire administration

Other: educational intervention

Procedure: quality-of-life assessment